Clinical trials
Biologics clinical trials
Below are recruiting biologics clinical trials, each written for real people, not researchers. We’re tracking 622 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07236177RecruitingEarly Phase 1
Enzyme test for early breast, lung, or pancreatic cancer
This study tests a new blood test that measures enzyme activity to detect localized cancer. It is for people with newly diagnosed, untreated breast, lung, or pancreatic cancer, as well as healthy volunteers.
PoitiersAges 18 years+ - NCT07234838Recruiting
Biologics for psoriasis and risk of genital warts
This study looks at whether biologic medicines for psoriasis affect the risk of developing genital warts. You may join if you have moderate to severe psoriasis and are starting or already on a biologic.
Brussels, Brussels CapitalAges 18 years+ - NCT07232277Recruiting
Vein congestion and kidney injury after heart surgery
This trial looks at how fluid buildup in veins might relate to kidney injury after planned heart surgery. It aims to find ways to prevent kidney damage. Participants must be having planned (non-emergency) heart surgery, be 18 or older, and have healthy kidneys and overall health.
Yangzhou, JiangsuAges 18 years+ - NCT06797297RecruitingPhase 2
Study of IBI363 vs pembrolizumab for advanced mucosal or acral melanoma
This trial tests a new drug, IBI363, compared to the standard drug pembrolizumab (Keytruda) for people with advanced mucosal or acral melanoma who have not had treatment before. It aims to see if IBI363 works better or as well as the usual treatment.
Hefei, AnhuiAges 18 years+ - NCT07230340Enrolling by invitationPhase 4
Placenta tissue for nonhealing leg ulcers
This study tests a special dehydrated human placenta tissue dressing for leg ulcers that won't heal. You will get either standard wound care plus this dressing, or standard care alone; later you may have the chance to receive the dressing.
Rocky Mount, North CarolinaAges 18 years+ - NCT07224555Enrolling by invitation
A gummy supplement for women with thinning hair
This study tests whether a daily gummy supplement called Xtressé can help with self-perceived thinning hair in women. If you are a woman between 18 and 65 who feels your hair is thinning, this trial may help determine if the supplement is effective for you.
Maitland, FloridaAges 18–65 - NCT07221773Enrolling by invitation
Microneedling with Xvie gel for thinning hair in women
This trial tests whether a new gel called Xvie, delivered into the scalp with tiny needles (microneedling), can help women who feel their hair is thinning. You will get the treatment in a clinic, and the study will see if it makes your hair look fuller.
Maitland, FloridaAges 28–65 - NCT07214324Recruiting
Predicting blood cancer progression with genetic analysis
This study uses advanced genetic testing to see if they can predict how monoclonal gammopathies (early blood conditions that may turn into cancer) will change over time. It may help doctors understand your risk better.
BolognaAges 18 years+ - NCT07212933RecruitingPhase 2
RAK cell therapy for advanced stomach cancer
This trial tests a new type of immune cell therapy called RAK cells for people with late-stage stomach cancer that has spread and stopped responding to standard treatments. The goal is to see if it is safe and helps control the cancer.
Beijing, Beijing MunicipalityAges 18–70 - NCT07218445RecruitingPhase 4
Tirzepatide for hot flashes in post-menopausal women with obesity
This study tests whether tirzepatide, a weekly injection, can reduce bothersome hot flashes and slow biological aging in post-menopausal women with obesity. It also includes a personalized diet and exercise plan.
Jacksonville, FloridaAges 46–60 - NCT07220473RecruitingPhase 2
Tirzepatide to slow biological aging
This study tests whether the medication tirzepatide (a drug used for diabetes and weight loss) can slow the biological aging process in adults aged 55 to 70 who have excess weight. You would take the medication as a weekly injection for a set period, and researchers will monitor changes in your body's health markers.
Galveston, TexasAges 55–70 - NCT07214610Recruiting
Improving breast cancer outcomes in North Carolina
This study looks at why some women with invasive breast cancer do better than others. It combines information from biology, medical history, and lifestyle to find ways to improve care and outcomes.
Chapel Hill, North CarolinaAges 20–74 - NCT07209475RecruitingPhase 4
Amnio-Maxx for healing diabetic foot ulcers
This trial tests whether a special wound dressing called Amnio-Maxx can help heal foot ulcers in people with diabetes. You may qualify if you have a diabetic foot ulcer that hasn't healed much with standard care.
Burbank, CaliforniaAges 18 years+ - NCT07203755RecruitingPhase 1
Combination vaccine for whooping cough, Hib, and meningitis
This trial tests a new combination vaccine that protects against whooping cough, Haemophilus influenzae type b (a cause of meningitis and pneumonia), and several types of meningococcal disease (a cause of meningitis and bloodstream infections). It may help reduce the number of shots needed for children.
Shangqiu, HenanAges 2 months–6 years - NCT07205198RecruitingPhase 1
Study of SIBP-A10 for advanced solid tumors
This trial tests a new drug called SIBP-A10 for people with advanced cancer that has not responded to other treatments. It aims to see if the drug is safe and helps shrink tumors.
Dalian, LiaoningAges 18–75 - NCT07202000RecruitingPhase 2
Exercise and a drug to reduce inflammation for heart failure with preserved ejection fraction
This trial tests whether combining exercise with a medication that blocks a protein called activin can reduce inflammation, improve heart function, and help with thinking in people with heart failure with preserved ejection fraction (HFpEF).
Boston, MassachusettsAges 40 years+ - NCT07198659RecruitingEarly Phase 1
New immune cell therapy for advanced pancreatic cancer
This trial tests a new treatment using your own immune cells (called neutrophils) that are loaded with a drug to fight pancreatic cancer that cannot be removed by surgery. It may be an option if standard treatments have stopped working or caused bad side effects.
Xi’an, ShanxiAges 18–70 - NCT07187817Recruiting
Sequential biologic treatments for psoriasis
This trial looks at how different biologic treatments work when used one after another for people with plaque psoriasis. It may help find the best order of treatments to keep your skin clear.
Bath, SomersetAges 18 years+ - NCT07193069Recruiting
Metformin overdose in the ICU – signs and dapagliflozin effects
This study looks at patients who are in the ICU after taking too much metformin (a diabetes drug), sometimes along with another drug called dapagliflozin (Farxiga). The goal is to understand how overdose affects the body and what signs doctors should watch for.
Saint-Denis, FranceAges 18 years+ - NCT07186556Recruiting
Exercise program for fatigue in young brain tumor survivors
This study tests whether a home-based exercise program (done through video calls) can help reduce fatigue in young adult brain tumor survivors. If you’re 18–39 and struggle with tiredness after treatment, this program may help you feel better.
Houston, TexasAges 18–39 - NCT07188532Recruiting
Personalized high-dose radiation for Ewing sarcoma
This trial tests a personalized radiation therapy that adjusts the dose based on your tumor. It aims to improve treatment for Ewing sarcoma while limiting side effects.
Phoenix, ArizonaAges 2 years+ - NCT07181525Recruiting
Predicting how well biologics work for IBD
This study builds a model to predict which biologic drug will work best for people with active inflammatory bowel disease (IBD). It uses data from patients already treated with biologics to help guide future treatment decisions.
BeijingAges 18 years+ - NCT02614911Recruiting
Genetics and health profile study for early severe bowel disease
This study looks at how an early-onset bowel illness looks and what genetic changes may be involved. It may help researchers better understand inherited causes and improve future care for families affected by these conditions.
BordeauxAges Any age - NCT07173829Recruiting
Study of why glioblastoma comes back
This trial collects tumor samples to study what causes glioblastoma to return. It may help scientists find better treatments.
BordeauxAges 18 years+
Hear when a new Biologics trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for biologics?
- Yes. Clin2 currently lists 622 recruiting biologics studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a biologics trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a biologics trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.